Compare WLAC & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WLAC | DERM |
|---|---|---|
| Founded | 2024 | 2014 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.1M | 257.1M |
| IPO Year | N/A | 2021 |
| Metric | WLAC | DERM |
|---|---|---|
| Price | $10.99 | $8.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $17.00 | $12.67 |
| AVG Volume (30 Days) | ★ 230.1K | 103.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,134,000.00 |
| Revenue This Year | N/A | $17.48 |
| Revenue Next Year | N/A | $55.83 |
| P/E Ratio | $784.60 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.96 | $4.97 |
| 52 Week High | $15.19 | $9.56 |
| Indicator | WLAC | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 34.95 | 55.01 |
| Support Level | $10.87 | $7.64 |
| Resistance Level | $11.32 | $8.29 |
| Average True Range (ATR) | 0.37 | 0.45 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 13.06 | 69.62 |
Willow Lane Acquisition Corp is a blank check company.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.